Literature DB >> 23334203

A genomic approach to active surveillance: a step toward precision medicine.

Eric A Klein1.   

Abstract

Mesh：

Year:  2013        PMID： 23334203      PMCID： PMC3739660          DOI： 10.1038/aja.2012.140

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  5 in total

Review 1.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

2.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

Authors:  Michael J O'Connell; Ian Lavery; Greg Yothers; Soonmyung Paik; Kim M Clark-Langone; Margarita Lopatin; Drew Watson; Frederick L Baehner; Steven Shak; Joffre Baker; J Wayne Cowens; Norman Wolmark
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

4.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

Review 5.  Active surveillance for prostate cancer: progress and promise.

Authors:  Matthew R Cooperberg; Peter R Carroll; Laurence Klotz
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544
  5 in total
  3 in total

1.  Global advances in prostate cancer diagnosis and therapy.

Authors:  Guneet Walia; Yinghao Sun; Howard R Soule
Journal:  Asian J Androl       Date:  2013-04-22       Impact factor: 3.285

Review 2.  [Prognostic and predictive molecular markers for urologic cancers].

Authors:  A Hartmann; T Schlomm; S Bertz; J Heinzelmann; S Hölters; R Simon; R Stoehr; K Junker
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639

3.  Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.

Authors:  Matteo Ferro; Giuseppe Lucarelli; Dario Bruzzese; Giuseppe Di Lorenzo; Sisto Perdonà; Riccardo Autorino; Francesco Cantiello; Roberto La Rocca; Gian Maria Busetto; Amelia Cimmino; Carlo Buonerba; Michele Battaglia; Rocco Damiano; Ottavio De Cobelli; Vincenzo Mirone; Daniela Terracciano
Journal:  Oncotarget       Date:  2017-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.